Pharmaceutical stocks to draw growing buy interest
Published: 2007-04-11 06:58:00
Updated: 2007-04-11 06:58:00
Despite the prevailing view that Korean companies can no longer expect success only by depending on making generic drugs in an era of the Korea-U.S. FTA, pharmaceutical stocks of major drug makers will increase gains, analysts said recently.
Analysts said that the outlook for the domestic phar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
